| abstract |
Compounds that inhibit the activity of particular tyrosine kinases are described herein. Methods for the preparation of such compounds are described. Pharmaceutical compositions that include the compounds are also described. Methods are provided for using the described compounds, alone or in combination with other therapeutic agents, for the treatment of diseases or conditions mediated by tyrosine kinases or diseases or conditions dependent on tyrosine, kinase. |